Compare Globus Medical Inc. Class A Common Stock (GMED) vs iShares TIPS Bond ETF (TIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs iShares TIPS Bond ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while iShares TIPS Bond ETF trades at $105.37 (market cap $14.33B). The key difference: iShares TIPS Bond ETF is the larger of the two by market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and iShares TIPS Bond ETF for 64 Days on average.
| GMED | TIP | |
|---|---|---|
Market Cap | $10.25B | $14.33B |
Volume | 1,108,124 | 1,485,284 |
Sector | Health | Fixed Income |
52-Week High | $96.82 | $112.20 |
52-Week Low | $58.33 | $103.98 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $9.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
TIP trades at $104.56 with minimal daily movement (+0.06%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The ETF shows limited price volatility with support at $104 and resistance at $105. Recent institutional activity includes Envestnet Asset Management increasing its stake by 3.5% in the latest quarter.
The ETF faces headwinds from rising Treasury yields and bond market volatility, though its inflation-protected structure provides defensive characteristics. Key risks include continued bond market selloffs and geopolitical tensions affecting oil prices. The upcoming dividend payment of $0.78 scheduled for August 2026 offers income stability amid market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About iShares TIPS Bond ETF
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →
